Research & Development

免费在线观看天无日天天射天天视天天啪天天舔天天透y贵州水城山体滑坡已搜救出遇难人员36人 失联15人


  雲瑯對衛伉道︰“告訴張連,這里的帳他付,不論鐘離遠給了他一百個金錠,還是兩百個金錠,他都必須還給鐘離遠。”   雲音,甦稚失望到了極點。免费在线观看   “他當然有伴手禮,淮南八駿的左吳就是他的伴手禮。”天无日天天射天天视   那四個泥雕木塑一般跪在那里的學徒,似乎被雲瑯的一聲斷喝,下的回了魂,各自呻吟一聲,軟軟的倒在地上,其中一個胯間很快就濡濕了一片。   曹襄吐出一個杏核道︰“長安哪里有什麼秘密可言,在有心人的推動下,你跟蜀中黃氏已經成了生死仇敵。”天天啪天天舔天天透y   連捷笑吟吟的給雲瑯牽過來一匹戰馬道︰“侯爺您快去,老奴留在家里看家。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo